Rapid microwave-assisted solution phase synthesis of 6,8-disubstituted 2-phenyl-3-(substituted- benzothiazol-2-yl)-4-[3H]-quinazolinones as novel anticonvulsants

Phosphorus, Sulfur and Silicon and the Related Elements

Volumn 183, Issue 9, 2008, Pages 2262-2273

  Laddha, Sachin S ^a   Bhatnagar, Satyendra P ^b  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

^b BIRLA INSTITUTE OF TECHNOLOGY   (India)

Author keywords

2 Phenyl 3 (benzothiazol 2 yl) 4 3H quinazolinone; 4 3H quinazolinone; Anticonvulsant; Microwave irradiation; Neurotoxicity

Indexed keywords

EID: 49549116448     PISSN: 10426507     EISSN: 15635325     Source Type: Journal    
DOI: 10.1080/10426500801957766     Document Type: Article

References (24)

1. N. D. P. Cosford, I. A. McDonald, and E. J. Schweiger, Annu. Res. Med., 33, 61 (1998).
2. S. J. Hays, M. J. Rice, D. F. Ortwine, G. Johnson, R. D. Schwarz, D. K. Boyd, L. F. Copeland, M. G. Vartanian, and P. A. Boxer, J. Pharm. Sci., 83, 1425 (1994).
3. J. Mizoule, B. Meldrum, M. Martine, M. Croucher, C. Ollak, A. Uzan, J. J. Legrand, C. Gueremy, and G. LeFur, Neuropharmacology, 24, 767 (1985).
4. J. Benavides, J. C. Camelln, N. Mitrani, F. Flamand, A. Uzan, J. J. Legrand, C. Gueremy, and G. LeFur, Neuropharmacology, 24, 1085 (1985).
5. S. J. Hays, R. D. Schwartz, D. K. Boyd, R. J. Anderson, and P. A. Boxer, National ACS Meeting. Atlanta, GA, MEDI, 6 (1991).
6. K. H. Boltze, H. D. Dell, H. Lehwald, D. Lorenz, and M. Ruberg-Schweer, Arzneim-Forsch., 13, 688 (1963).
7. M. A. Gujral, P. N. Saxena, and R. S. Tiwari, Indian J. Chem., 43, 637 (1955).
8. C. M. Gupta, A. P. Bhaduri, and N. W. Khanna, Indian J. Chem., 7, 866 (1969).
9. I. R. Ager, D. R. Harrison, P. D. Kennewell, and J. B. Taylor, J. Med. Chem., 20, 379 (1977).
10. A. Lata, R. K. Satsangi, Y. K. Srivastava, and K. Kishor, Arzeneim-Forsch., 32, 24 (1982).
11. M. I. Husain and E. Singh, Pharmazie, 37, 408 (1982).
12. M. J. Kornet, T. Varia, and W. J. Beaven, Heterocycl. Chem., 20, 1553 (1983).
13. N. A. Vaidya, C. H. Panos, A. Kite, W. B. Iturrian, and D. Blanton, J . Med. Chem., 26, 1422 (1983).
14. M. I. Hussain and M. J. Amir, J. Chem. Soc. Pak., 6, 211 (1984).
15. S. Buyuktimkin, Arch. Pharmacol., 319, 933 (1986), and references cited therein.
16. M. J. Kornet, Eur. J. Med. Chem., 21, (1986).
17. N. Deshpande, Y. V. Rao, R. P. Kandlikar, A. D. Rao, and Y. M. Reddy, Indian J. Pharmacol., 18, 127 (1986).
18. R. K. Saksena and R. Yasmeen, Indian J. Chem., 25B, 438 (1986).
19. I. K. Kacker and S. H. Zaheer, J. Indian Chem. Soc., 28, 344 (1951).
20. S. S. Laddha, S. G. Wadodkar, and S. K. Meghal, ARKIVOC (xi), 1 (2006).
21. J. Trefouel, M. Trefouel, F. Nitti, and D. Bovet, Chem. Res. Soc. Bio., 120, 756 (1935).
22. D. T. Zentmyer and E. C. Wagner, J. Org. Chem., 14, 967 (1949).
23. E. A. Swinyard, J. Woodhead, H. S. White, and M. R. Franklin, In: Antiepileptic Drugs, 3rd Ed, (Raven Press, New York, 1989), p. 85.
24. N. W. Dunham and T. S. Miya, J. Am. Pharmacol. Assoc., 46, 208 (1957).